Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

28.32

+0.87 (3.17%)

Feb 24, 2026, 4:00 PM EST - Market closed

Enliven Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,681	1,099	570	-	-	-
Market Cap Growth	53.09%	92.74%	-	-	-	-
Enterprise Value	1,204	808	307	-	-	-
Last Close Price	28.32	22.50	13.84	-	-	-
PB Ratio	3.52	3.55	2.32	-	-	-
P/TBV Ratio	3.53	3.55	2.32	-	-	-
Debt / Equity Ratio	0.00	-	0.00	0.01	0.00	0.00
Net Debt / Equity Ratio	-1.00	-1.01	-1.03	-1.03	-1.03	-1.01
Net Debt / EBITDA Ratio	4.26	3.01	3.09	1.94	4.46	14.05
Net Debt / FCF Ratio	6.64	4.28	4.12	2.29	5.69	14.49
Quick Ratio	32.60	19.70	9.78	7.78	19.13	88.20
Current Ratio	32.95	19.99	10.28	8.00	19.24	88.35
Return on Equity (ROE)	-25.43%	-32.04%	-44.90%	-41.90%	-20.94%	-
Return on Assets (ROA)	-17.62%	-21.87%	-28.94%	-24.66%	-12.67%	-
Return on Capital Employed (ROCE)	-23.60%	-33.70%	-33.40%	-52.70%	-23.00%	-7.20%
Earnings Yield	-5.78%	-8.10%	-12.55%	-	-	-
FCF Yield	-4.27%	-6.66%	-10.77%	-	-	-
Buyback Yield / Dilution	-19.30%	-32.43%	-1037.74%	60.02%	-56.70%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q